Lisa Rojkjaer
2020
In 2020, Lisa Rojkjaer earned a total compensation of $809.8K as Chief Medical Officer at Sunesis Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $148,405 |
|---|---|
| Option Awards | $320,807 |
| Salary | $246,667 |
| Other | $93,938 |
| Total | $809,817 |
Rojkjaer received $320.8K in option awards, accounting for 40% of the total pay in 2020.
Rojkjaer also received $148.4K in non-equity incentive plan, $246.7K in salary and $93.9K in other compensation.
Rankings
In 2020, Lisa Rojkjaer's compensation ranked 9,453rd out of 13,090 executives tracked by ExecPay. In other words, Rojkjaer earned more than 27.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,453 out of 13,090 | 28th |
Division Manufacturing | 4,049 out of 5,624 | 28th |
Major group Chemicals And Allied Products | 1,645 out of 2,257 | 27th |
Industry group Drugs | 1,441 out of 1,957 | 26th |
Industry Pharmaceutical Preparations | 1,058 out of 1,462 | 28th |
Source: SEC filing on April 27, 2022.
Rojkjaer's colleagues
We found two more compensation records of executives who worked with Lisa Rojkjaer at Sunesis Pharmaceuticals in 2020.